Merck KGaA: substantial increases in revenue and employment levels in 2017
…173m (€38m) in 2017, a 22% year-on-year increase. Staff levels grew by 50%, from 43 people in 2016. In September 2017 the company received market authorisation for two drugs – one is used in the treatment of multiple sclerosis, and the other in cases of skin cancer.
Sign up now to open the entire news item.You are allowed to open only one news item from PMR websites.
(to send requested information)
(required for new e-mails only)